Resveratrol-mediated downregulation of rictor attenuates autophagic process and suppresses UV-induced skin carcinogenesis

Photochemistry and Photobiology

Volumn 88, Issue 5, 2012, Pages 1165-1172

  Back, Jung H ^a   Zhu, Yucui ^a   Calabro, Alyssa ^b   Queenan, Craig ^b   Kim, Audrey S ^b   Arbesman, Joshua ^a   Kim, Arianna L ^a  

^a Department of Medicine   (United States)

^b Nano Structural Imaging Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARRIER PROTEIN; LIGHT CHAIN 3, HUMAN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MICROTUBULE ASSOCIATED PROTEIN; MULTIPROTEIN COMPLEX; RESVERATROL; RICTOR PROTEIN, MOUSE; STILBENE DERIVATIVE; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2; TUMOR MARKER;

ANIMAL; AUTOPHAGY; CELL AGING; CONFERENCE PAPER; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HAIRLESS MOUSE; HUMAN; METABOLISM; MOUSE; PATHOLOGY; PHAGOSOME; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; SKIN; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AUTOPHAGY; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL AGING; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; MICE; MICE, HAIRLESS; MICROTUBULE-ASSOCIATED PROTEINS; MULTIPROTEIN COMPLEXES; PHAGOSOMES; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; STILBENES; TOR SERINE-THREONINE KINASES; TUMOR MARKERS, BIOLOGICAL; ULTRAVIOLET RAYS;

MURINAE;

EID: 84865957147     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2012.01097.x     Document Type: Conference Paper

References (59)

1. Woodhead, A. D., R. B. Setlow, and, M. Tanaka, (1999) Environmental factors in nonmelanoma and melanoma skin cancer. J. Epidemiol. 9, S102-S114.
2. Saldanha, G., (2001) The Hedgehog signalling pathway and cancer. J. Pathol. 193, 427-432. (Pubitemid 32266810)
3. Amstad, P. A., and, P. A. Cerutti, (1995) Ultraviolet-B-light-induced mutagenesis of C-H-ras codons 11 and 12 in human skin fibroblasts. Int. J. Cancer 63, 136-139.
4. Nishigori, C., (2006) Cellular aspects of photocarcinogenesis. Photochem. Photobiol. Sci. 5, 208-214. (Pubitemid 43228049)
5. Jimeno, A., P. Kulesza, J. Wheelhouse, A. Chan, X. Zhang, E. Kincaid, R. Chen, D. P. Clark, A. Forastiere, and, M. Hidalgo, (2007) Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy. Br. J. Cancer 96, 952-959. (Pubitemid 46452288)
6. Khariwala, S. S., J. Kjaergaard, R. Lorenz, F. Van Lente, S. Shu, and, M. Strome, (2006) Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII). Laryngoscope 116, 814-820. (Pubitemid 44318043)
7. Feldmeyer, L., G. F. Hofbauer, T. Boni, L. E. French, and, J. Hafner, (2012) Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing. Br. J. Dermatol. 166, 422-424.
8. Han, W., M. Ming, T. C. He, and, Y. Y. He, (2010) Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis. J. Biol. Chem. 285, 11369-11377.
9. Monaco, A. P., (2009) The role of mTOR inhibitors in the management of posttransplant malignancy. Transplantation 87, 157-163.
10. Ulrich, C., J. Kanitakis, E. Stockfleth, and, S. Euvrard, (2008) Skin cancer in organ transplant recipients - where do we stand today? Am. J. Transplant. 8, 2192-2198.
11. Jensen, P., S. Hansen, B. Moller, T. Leivestad, P. Pfeffer, O. Geiran, P. Fauchald, and, S. Simonsen, (1999) Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J. Am. Acad. Dermatol. 40, 177-186. (Pubitemid 29072794)
12. Schmelzle, T., and, M. N. Hall, (2000) TOR, a central controller of cell growth. Cell 103, 253-262.
13. Rubinsztein, D. C., J. E. Gestwicki, L. O. Murphy, and, D. J. Klionsky, (2007) Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov. 6, 304-312. (Pubitemid 46505881)
14. Kondo, Y., and, S. Kondo, (2006) Autophagy and cancer therapy. Autophagy 2, 85-90.
15. Shintani, T., and, D. J. Klionsky, (2004) Autophagy in health and disease: a double-edged sword. Science 306, 990-995. (Pubitemid 39482894)
16. Notte, A., and, L. C. Leclere, (2011) Autophagy as a mediator of chemotherapy-induced cell death in cancer. Biochem. Pharmacol. 82, 427-434.
17. Yu, L., A. Alva, H. Su, P. Dutt, E. Freundt, S. Welsh, E. H. Baehrecke, and, M. J. Lenardo, (2004) Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304, 1500-1502. (Pubitemid 38720930)
18. Paglin, S., T. Hollister, T. Delohery, N. Hackett, M. McMahill, E. Sphicas, D. Domingo, and, J. Yahalom, (2001) A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 61, 439-444. (Pubitemid 32128593)
19. Amaravadi, R. K., D. Yu, J. J. Lum, T. Bui, M. A. Christophorou, G. I. Evan, A. Thomas-Tikhonenko, and, C. B. Thompson, (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 117, 326-336. (Pubitemid 46203961)
20. Yue, Z., S. Jin, C. Yang, A. J. Levine, and, N. Heintz, (2003) Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl Acad. Sci. USA 100, 15077-15082. (Pubitemid 37518019)
21. Crazzolara, R., K. F. Bradstock, and, L. J. Bendall, (2009) RAD001 (Everolimus) induces autophagy in acute lymphoblastic leukemia. Autophagy 5, 727-728.
22. Athar, M., J. H. Back, L. Kopelovich, D. R. Bickers, and, A. L. Kim, (2009) Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms. Arch. Biochem. Biophys. 486, 95-102.
23. Goswami, S. K., and, D. K. Das, (2009) Resveratrol and chemoprevention. Cancer Lett. 284, 1-6.
24. Aggarwal, B. B., A. Bhardwaj, R. S. Aggarwal, N. P. Seeram, S. Shishodia, and, Y. Takada, (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 24, 2783-2840. (Pubitemid 39409568)
25. Aziz, M. H., F. Afaq, and, N. Ahmad, (2005) Prevention of ultraviolet-B radiation damage by resveratrol in mouse skin is mediated via modulation in survivin. Photochem. Photobiol. 81, 25-31. (Pubitemid 40327556)
26. Reagan-Shaw, S., F. Afaq, M. H. Aziz, and, N. Ahmad, (2004) Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin. Oncogene 23, 5151-5160. (Pubitemid 38980348)
27. Kim, K. H., J. H. Back, Y. Zhu, J. Arbesman, M. Athar, L. Kopelovich, A. L. Kim, and, D. R. Bickers, (2011) Resveratrol targets transforming growth factor-beta2 signaling to block UV-induced tumor progression. J. Invest. Dermatol. 131, 195-202.
28. Back, J. H., H. R. Rezvani, Y. Zhu, V. Guyonnet-Duperat, M. Athar, D. Ratner, and, A. L. Kim, (2011) Cancer cell survival following DNA damage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent inhibition of sirtuin 1. J. Biol. Chem. 286, 19100-19108.
29. Mooi, W. J., and, D. S. Peeper, (2006) Oncogene-induced cell senescence - halting on the road to cancer. N. Engl. J. Med. 355, 1037-1046. (Pubitemid 44343547)
30. Campisi, J., (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513-522. (Pubitemid 40269765)
31. Gerland, L. M., S. Peyrol, C. Lallemand, R. Branche, J. P. Magaud, and, M. French, (2003) Association of increased autophagic inclusions labeled for beta-galactosidase with fibroblastic aging. Exp. Gerontol. 38, 887-895. (Pubitemid 36952670)
32. Gary, R. K., and, S. M. Kindell, (2005) Quantitative assay of senescence-associated beta-galactosidase activity in mammalian cell extracts. Anal. Biochem. 343, 329-334. (Pubitemid 41074047)
33. Kim, A. L., M. Athar, D. R. Bickers, and, J. Gautier, (2002) Ultraviolet-B-induced G1 arrest is mediated by downregulation of cyclin-dependent kinase 4 in transformed keratinocytes lacking functional p53. J. Invest. Dermatol. 118, 818-824. (Pubitemid 34526544)
34. Kim, A. L., M. Athar, D. R. Bickers, and, J. Gautier, (2002) Stage-specific alterations of cyclin expression during UVB-induced murine skin tumor development. Photochem. Photobiol. 75, 58-67.
35. Wu, Y. C., W. K. Wu, Y. Li, L. Yu, Z. J. Li, C. C. Wong, H. T. Li, J. J. Sung, and, C. H. Cho, (2009) Inhibition of macroautophagy by bafilomycin A1 lowers proliferation and induces apoptosis in colon cancer cells. Biochem. Biophys. Res. Commun. 382, 451-456.
36. Groth-Pedersen, L., M. S. Ostenfeld, M. Hoyer-Hansen, J. Nylandsted, and, M. Jaattela, (2007) Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine. Cancer Res. 67, 2217-2225. (Pubitemid 46424241)
37. Kochl, R., X. W. Hu, E. Y. Chan, and, S. A. Tooze, (2006) Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes. Traffic 7, 129-145.
38. Bursch, W., K. Hochegger, L. Torok, B. Marian, A. Ellinger, and, R. S. Hermann, (2000) Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J. Cell Sci. 113 (Pt 7), 1189-1198. (Pubitemid 30229536)
39. Reggiori, F., I. Monastyrska, T. Shintani, and, D. J. Klionsky, (2005) The actin cytoskeleton is required for selective types of autophagy, but not nonspecific autophagy, in the yeast Saccharomyces cerevisiae. Mol. Biol. Cell 16, 5843-5856. (Pubitemid 41752231)
40. Bozulic, L., and, B. A. Hemmings, (2009) PIKKing on PKB: regulation of PKB activity by phosphorylation. Curr. Opin. Cell Biol. 21, 256-261.
41. Martin, D. E., and, M. N. Hall, (2005) The expanding TOR signaling network. Curr. Opin. Cell Biol. 17, 158-166. (Pubitemid 40380939)
42. Sarbassov, D. D., S. M. Ali, and, D. M. Sabatini, (2005) Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17, 596-603. (Pubitemid 41540408)
43. Sarbassov, D. D., D. A. Guertin, S. M. Ali, and, D. M. Sabatini, (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101. (Pubitemid 40262113)
44. Jacinto, E., R. Loewith, A. Schmidt, S. Lin, M. A. Ruegg, A. Hall, and, M. N. Hall, (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122-1128. (Pubitemid 39468014)
45. Brunk, U. T., and, A. Terman, (2002) The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur. J. Biochem. 269, 1996-2002. (Pubitemid 34437840)
46. Terman, A., H. Dalen, J. W. Eaton, J. Neuzil, and, U. T. Brunk, (2003) Mitochondrial recycling and aging of cardiac myocytes: the role of autophagocytosis. Exp. Gerontol. 38, 863-876. (Pubitemid 36952668)
47. Opipari, A. W., L. Tan, A. E. Boitano, D. R. Sorenson, A. Aurora, and, J. R. Liu, (2004) Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res. 64, 696-703. (Pubitemid 38120912)
48. Trincheri, N. F., C. Follo, G. Nicotra, C. Peracchio, R. Castino, and, C. Isidoro, (2008) Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes. Carcinogenesis 29, 381-389. (Pubitemid 351359678)
49. Armour, S. M., J. A. Baur, S. N. Hsieh, A. Land-Bracha, S. M. Thomas, and, D. A. Sinclair, (2009) Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy. Aging (Albany NY) 1, 515-528.
50. Lee, I. H., L. Cao, R. Mostoslavsky, D. B. Lombard, J. Liu, N. E. Bruns, M. Tsokos, F. W. Alt, and, T. Finkel, (2008) A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl Acad. Sci. USA 105, 3374-3379. (Pubitemid 351723560)
51. Munoz-Gamez, J. A., J. M. Rodriguez-Vargas, R. Quiles-Perez, R. Aguilar-Quesada, D. Martin-Oliva, G. de Murcia, J. de Murcia, A. Almendros, M. de Almodovar, and, F. J. Oliver, (2009) PARP-1 is involved in autophagy induced by DNA damage. Autophagy 5, 61-74.
52. Lee, J. Y., Y. Koga, W. Kawaguchi, E. Tang, Y. S. Wong, U. B. Gao, S. Pandey, E. Kaushik, E. Tresse, J. Lu, J. P. Taylor, A. M. Cuervo, and, T. P. Yao, (2010) HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. EMBO J. 29, 969-980.
53. Lee, J., I. Lee, C. Park, and, W. K. Kang, (2006) Lovastatin-induced RhoA modulation and its effect on senescence in prostate cancer cells. Biochem. Biophys. Res. Commun. 339, 748-754. (Pubitemid 41772877)
54. Guertin, D. A., D. M. Stevens, M. Saitoh, S. Kinkel, K. Crosby, J. H. Sheen, D. J. Mullholland, M. A. Magnuson, H. Wu, and, D. M. Sabatini, (2009) mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. Cancer Cell 15, 148-159.
55. Masri, J., A. Bernath, J. Martin, O. D. Jo, R. Vartanian, A. Funk, and, J. Gera, (2007) mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. Cancer Res. 67, 11712-11720.
56. Huang, Q., and, H. M. Shen, (2009) To die or to live: the dual role of poly(ADP-ribose) polymerase-1 in autophagy and necrosis under oxidative stress and DNA damage. Autophagy 5, 273-276.
57. Rodriguez-Rocha, H., A. Garcia-Garcia, M. I. Panayiotidis, and, R. Franco, (2011) DNA damage and autophagy. Mutat. Res. 711, 158-166.
58. Kaushik, S., and, A. M. Cuervo, (2006) Autophagy as a cell-repair mechanism: activation of chaperone-mediated autophagy during oxidative stress. Mol. Aspects Med. 27, 444-454. (Pubitemid 44472625)
59. Massey, A. C., S. Kaushik, G. Sovak, R. Kiffin, and, A. M. Cuervo, (2006) Consequences of the selective blockage of chaperone-mediated autophagy. Proc. Natl Acad. Sci. USA 103, 5805-5810.